Detalhe da pesquisa
1.
A Phase 1/2 trial of SRA737 (a Chk1 inhibitor) administered orally in patients with advanced cancer.
Br J Cancer
; 129(1): 38-45, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37120671
2.
Precision oncology using ex vivo technology: a step towards individualised cancer care?
Expert Rev Mol Med
; 24: e39, 2022 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36184897
3.
Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial.
Lancet Oncol
; 22(11): 1530-1540, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34656227
4.
The DANTE trial protocol: a randomised phase III trial to evaluate the Duration of ANti-PD-1 monoclonal antibody Treatment in patients with metastatic mElanoma.
BMC Cancer
; 21(1): 761, 2021 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34210290
5.
Online monitoring of patient self-reported adverse events in early phase clinical trials: Views from patients, clinicians, and trial staff.
Clin Trials
; 18(2): 168-179, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33231103
6.
Radium-223 in combination with paclitaxel in cancer patients with bone metastases: safety results from an open-label, multicenter phase Ib study.
Eur J Nucl Med Mol Imaging
; 46(5): 1092-1101, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30547207
7.
Genome-Wide Analysis of Circulating Cell-Free DNA Copy Number Detects Active Melanoma and Predicts Survival.
Clin Chem
; 64(9): 1338-1346, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29941468
8.
Individualized cancer vaccines versus surveillance after adjuvant chemotherapy for surgically resected high-risk stage 2 and stage 3 colorectal cancer: protocol for a randomized trial.
Br J Surg
; 110(12): 1883-1884, 2023 11 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37856683
9.
CONFIRM trial: what is the real efficacy of second-line immunotherapy in mesothelioma? - Authors' reply.
Lancet Oncol
; 23(1): e14-e15, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34973224
10.
Importance of clinical research for the UK's 10-year cancer plan.
Lancet Oncol
; 23(8): 975-978, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35691298
11.
Effect of methotrexate on JAK/STAT pathway activation in myeloproliferative neoplasms.
Lancet
; 385 Suppl 1: S98, 2015 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-26312921
12.
The relationship between smoking and quality of life in advanced lung cancer patients: a prospective longitudinal study.
Support Care Cancer
; 24(4): 1507-16, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26364190
13.
Coping with melanoma-related worry: a qualitative study of the experiences and support needs of patients with malignant melanoma.
J Clin Nurs
; 24(7-8): 937-47, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25660824
14.
Adjuvant bevacizumab in patients with melanoma at high risk of recurrence (AVAST-M): preplanned interim results from a multicentre, open-label, randomised controlled phase 3 study.
Lancet Oncol
; 15(6): 620-30, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24745696
15.
Are we over-treating with checkpoint inhibitors?
Br J Cancer
; 121(8): 629-630, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31527686
16.
In-vitro assays for immuno-oncology drug efficacy assessment and screening for personalized cancer therapy: scopes and challenges.
Expert Rev Clin Immunol
; : 1-18, 2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38546609
17.
A three-arm randomised phase II study of the MEK inhibitor selumetinib alone or in combination with paclitaxel in metastatic uveal melanoma.
Eur J Cancer
; 202: 114009, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38547774
18.
A randomised phase 2 study of intermittent versus continuous dosing of dabrafenib plus trametinib in patients with BRAFV600 mutant advanced melanoma (INTERIM).
Eur J Cancer
; 196: 113455, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38029480
19.
Exercise to transform tumours from cold to hot and improve immunotherapy responsiveness.
Front Immunol
; 14: 1335256, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38149260
20.
Mental health burden for NHS healthcare staff during the COVID-19 pandemic: First results of a longitudinal survey.
Heliyon
; 9(3): e13765, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36811018